Skip to content
healthcare.dev

Buprenorphine and Naloxone Sublingual Film

NDC 47781-357, Buprenorphine and Naloxone, film, from Alvogen Inc..

Product NDC
47781-357
Status
Listed
Labeler
Alvogen Inc.
Dosage form
FILM
Route
BUCCAL, SUBLINGUAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205954
DEA schedule
CIII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/47781-357 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPRENORPHINE HYDROCHLORIDE8 mg/1
  • NALOXONE HYDROCHLORIDE DIHYDRATE2 mg/1

Pharmacologic classes

Opioid Antagonist [EPC]; Opioid Antagonists [MoA]; Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]

Package NDCNDC-11Package
47781-357-034778103570330 POUCH in 1 CARTON (47781-357-03) / 1 FILM in 1 POUCH (47781-357-11)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4210afeb-474c-d842-d68e-af7e0021851a
  • NADAC price for package 47781035703

    GET /v1/drugs/nadac/47781035703

Use it

Look up 47781-357 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/47781-357 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 47781-357. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.